trial · primary record
brivekimig
Crohn's Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 99 |
| Primary completion | 2029-10-17 |
| Primary endpoint | Percentage of participants who achieve endoscopic response at Week 16 |
| Registry ID | NCT06958536 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:08.741Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06958536
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.